David H. Harpole
Duke University · 310 works · 20,285 citations · h-index 73
Top works
- Oncogenic pathway signatures in human cancers as a guide to targeted therapies
- A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.
- Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial
- Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database
- Data from The Society of Thoracic Surgeons General Thoracic Surgery database: The surgical management of primary lung tumors
- RETRACTED: A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer
- Genomic signatures to guide the use of chemotherapeutics
- Thoracoscopic Lobectomy Is a Safe and Versatile Procedure
- Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
- Prognostic models of thirty-day mortality and morbidity after major pulmonary resection
- Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence
- Outcomes after esophagectomy: a ten-year prospective cohort
- Correlation of Tumor Size and Survival in Patients With Stage IA Non-small Cell Lung Cancer
- Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy
- Thoracoscopic Lobectomy Facilitates the Delivery of Chemotherapy after Resection for Lung Cancer
- Reducing Hospital Morbidity and Mortality Following Esophagectomy
- Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
- Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non–small cell lung cancer
- A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers
- Extrapleural Pneumonectomy in the Multimodality Therapy of Malignant Pleural Mesothelioma